CORINNE KURTZER: Open Payments
NPI 1720852197 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 53 payments from 19 companies in 2025. Trend: 2023 $302 · 2024 $1,423 · 2025 $1,119
Food & beverage: $991Education: $128
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $360 |
| Amgen Inc. | 1 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $80 |
| E.R. Squibb & Sons, L.L.C. | 5 | $79 |
| LEO Pharma Inc. | 4 | $61 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
| ABBVIE INC. | 3 | $46 |
| Lilly USA, LLC | 3 | $44 |
| STRATA Skin Sciences, Inc. | 3 | $37 |
Products named: TREMFYA, OTEZLA, COSENTYX, Sotyktu, DUPIXENT, NEMLUVIO, SKYRIZI, ADBRY.
Industry payments across NJ — which companies pay providers there.
